Item No: M4-00550
UPC: 834266005505
Epozine-O2 NT
180 Tablets
Our Price: $44.89
Retail: $72.99
Features
Vascularity* - Pumps* - Size* - Strength* - Recovery*
Anabolic Mediator & Ergogenic Plasma Volumizer*
- Evolution Series
- N-Tensity Technology
- Official Nutritional Supplement Provider
of the UFC Ultimate Fighting Championship
Unlock Your Muscular Evolution!*
Epozine-O2 NT Product Highlights:
Epozine-O2 NT is designed to support:
- Strength, Power, Endurance & Recovery*
- VO2max -- Maximal Oxygen Consumption -- Aerobic Capacity*
- Blood Flow and Delivery of Nutrients to Muscle Tissue*
- Oxygen (O2) Uptake, Capacity & Delivery*
- Protein Synthesis -- Anabolism*
- Physical Performance*
- Insulin already within the normal range*
- ATP Resynthesis*
- Controlled Release*
- Erythropoietin already within the normal range*
- Muscle Carnosine Content*
- Resistance To Muscular Fatigue -- Anti-Fatigue*
- Hydrogen Ion (H+) Buffering*
- Anaerobic Working Capacity of Muscle Tissue*
- Nitric Oxide (N.O.) already within the normal range*
- Muscle Fullness, Vascularity & Full-Body Pumps*
- Regulated Muscle Degradation -- Anti-Catabolism*
Designed For: Healthy adults 18-50 years of age seeking to support or enhance lean muscle, physical performance and recovery.*
Ingredients
Supplement Facts
Serving Size 3 Tablets
Servings Per Container 60
| Amount Per Serving | % Daily Value |
| Niacin (Vitamin B3) | 12 mg | 60% |
| Folate (Folic Acid) | 30 mcg | 8% |
| NITROS (Nitric Oxide Matrix)* | 2.4 g | ** |
| L-Arginine Alpha-Ketoglutarate | | |
| L-Norvaline | | |
| Gamma-Butyrobetaine Ethyl Ester | | |
| L-Arginine Aspartate | | |
| L-Citrulline-Malic Acid Matrix | | |
| L-Arginine Pyroglutamate | | |
| Magnesium Tanshinoate B (MTB) | | |
| L-Arginine Ethyl Ester DiHCl | | |
| L-Histidine | | |
| Folate | | |
| CRTS2 (Controlled Release Technology & Support System)* | 2.2 g | ** |
Hydroxypropyl Methylcellulose
(A Micro-Polymer Hydrophilic Matrix) | | |
| Myogenic Endura Shot* | | ** |
| Beta-Alanine (CarnoSyn) | | |
| Creatine-Sodium Phosphate Matrix | | |
| Creatinol-O-Phosphate | | |
| Creatine Magnesium Chelate (Magna Power) | | |
| 6-Methyluracil | | |
| Adenosine 5'Triphosphate Disodium (Peak ATP) | | |
| Niacin | | |
| NAD (Nicotinamide Adenine Dinucleotide) | | |
| Oxygen Capacity Composite* | | ** |
| DiCalcium Phosphate | | |
| Di-Potassium Phosphate | | |
| Di-Sodium Phosphate | | |
| Cytidine 5'Monophosphate | | |
| Uridine 5'Monohosphate | | |
| Guanosine 5'Monophosphate | | |
| Adenosine 5'Monophosphate | | |
| Inosine 5'Monophosphate' | | |
| Inositol Hexaphosphate | | |
| Anabolic Red Mass Interfusion* | | ** |
Purple Coneflower (leaf)
(2% Polyphenols) | | |
| Barbary Wolfberry (fruit & leaf) | | |
Membranous Milk Vetch (root)
(0.3% Astragalosides) | | |
Chinese Angelica (root)
(0.1% Ligustilide) | | |
| White Peony Root Extract | | |
Purslane (aboveground parts)
(5% Flavones) | | |
| Insulino-Memetic Matrix* | | ** |
| Cinnulin PF (Cinnamon Extract) (bark) | | |
| Banaba (leaf) (18% Colosolic Acid) | | |
| Bis-Glycinato-Oxovanadium (BGOV) | | |
| Bis-Picolinate-Oxovanadium (BPOV) | | |
** Daily Value not established.
Other Ingredients: Stearic Acid, Calcium Silicate, Magnesium Stearate, Microcrystalline Cellulose, Hydroxypropyl Methylcellulose, Silica, Triacetin, FD&C Red #40.
Directions For Use
Recommended use for persons under 200 lbs: As a dietary supplement, take 3 tablets 3 times per day, every day.
Always take Epozine-O2 NT on an empty stomach (i.e. approximately 30-45 minutes before meals or 2 hours after a meal). Taking Epozine-O2 NT with food or on a full stomach may diminish its effects.
Take the first 3 tablets in the morning upon rising, the second 3 tablets before lunch, and the third 3 tablets before dinner.
Recommended use for persons over 200 lbs: Follow the same guidelines as above, but take 4 tablets 3 times per day, every day, on an empty stomach.
Warnings
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
